The treatment and prevention of acute ischemic stroke

Authors

  • Alvaro Nagib Atallah Universidade Federal de São Paulo

Downloads

Download data is not yet available.

Author Biography

Alvaro Nagib Atallah, Universidade Federal de São Paulo

MD, PhD, MSc Chairman, Department of Internal Medicine, Escola Paulista de Medicina, Editor, Sao Paulo Medical Journal.

References

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.

Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-93.

Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in the treatment of acute ischaemic stroke. Lancet 1995;346:1509-14.

Longestreth W. Tissue Plasminogen activator improved clinical outcome after acute ischemic stroke - Commentary . Evidence Based Medicine 1996; 4: 106-7.

Pearce KA, Furberg CD, Rushing J. Does antihypertensive treatment of the elderly prevent cardiovascular events or prolong life? A meta-analysis of hypertension treatment trials. Arch Fam Med 1995;4:943-50.

Antiplatelet Trialists' Collaboration. Collaborative overview of randomized therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81-106.

Downloads

Published

1996-11-11

How to Cite

1.
Atallah AN. The treatment and prevention of acute ischemic stroke. Sao Paulo Med J [Internet]. 1996 Nov. 11 [cited 2025 Mar. 12];114(6):1291-2. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2050

Issue

Vol. 114 No. 6 (1996)

Section

Editorial

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.